Company Filing History:
Years Active: 2011
Title: Terence William Spithill: Innovator in Chagas Disease Biomarkers
Introduction
Terence William Spithill is a notable inventor based in Notre-Dame, CA. He has made significant contributions to the field of medical diagnostics, particularly in relation to Chagas disease. His innovative work focuses on the development of protein-based biomarkers that can aid in the diagnosis and classification of this disease.
Latest Patents
Spithill holds a patent for "Serum biomarkers for Chagas disease." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Chagas disease status in a patient. The biomarkers developed by Spithill are particularly effective in classifying a subject sample as either infected with Chagas disease or non-infected. These biomarkers can be detected using SELDI mass spectrometry, showcasing a significant advancement in diagnostic techniques.
Career Highlights
Terence William Spithill is affiliated with McGill University, where he continues to engage in research and innovation. His work has garnered attention for its potential impact on public health, especially in regions where Chagas disease is prevalent.
Collaborations
Some of his notable coworkers include Momar Ndao and Brian Ward, who have collaborated with him on various research projects. Their combined expertise contributes to the advancement of knowledge in the field of infectious diseases.
Conclusion
Terence William Spithill's contributions to the field of Chagas disease diagnostics through his innovative patent highlight the importance of research in improving health outcomes. His work exemplifies the role of inventors in addressing critical health challenges.